Global CROs Services Market Size - Forecasts to 2026

The findings reviewed by GME stated that the Global Contract Research Organization (CROs) Services Market will expand at a CAGR value of 9.62% to reach USD 85.61 billion by 2026 from USD 51.25 billion by 2021. The market is likely to be driven by the growing number of clinical testing, growing incidence of rare diseases, and rising investments in biopharmaceutical and pharmaceutical R&D activities.

Browse 155 Market Data Tables and 115 Figures spread through 187 Pages and in-depth TOC on “Global Contract Research Organization (CROs) Services Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/contract-research-organization-cros-services-market-3411

By Molecule Type (Vaccines, Cell Gene Therapy, Others), By Therapeutic Area (Hematology, Oncology, Infectious Disease, Neurology, Metabolic Disorders/Endocrinology, Cardiovascular System Disorders, Ophthalmology, Immunological Disorders, Dermatology, Psychiatry, Gastrointestinal Diseases, Genitourinary & Women’s Health, Others), By Type (Clinical Research Services, Early-Phase Development Services, Laboratory Services, Consulting Services, Data Management Services), By End-User (Pharmaceutical and Biopharmaceutical, Academic Institutes, Medical Device Components), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis.

Key Market Insights
• As per a recent survey by clinicaltrials.gov, number of oncology clinical trials worldwide increased from over 2,400 in 2007 to over 10,000 in 2019
• The clinical research services segment is expected to hold the lion’s share during the forecast period 2021-2026
• The pharmaceutical and biopharmaceutical segment is expected to grow at the highest CAGR rate from 2021 to 2026
• The increasing number of pharmaceutical firms, and rising preference for low-cost treatment for clinical trials, Asia Pacific is expected to grow at the highest CAGR rate during the forecast period
• Some of the key players in the contract research organization (CROs) services market are IQVIA, Labcorp, Syneos Health Inc., Wuxi Apptec, Charles River Laboratories, Parexel International, PRA Health Sciences, PPD Inc., Icon Plc, Medpace Holdings Inc., SGS, Frontage Holdings Corporation, PSI CRO AG, Bio Agile Therapeutics, Firma Clinical Research, Acculab Life Sciences, Novotech Health Holding, Geneticist Inc., And Celerion, among others.

Browse the Report @ 26” https://www.globalmarketestimates.com/market-report/contract-research-organization-cros-services-market-3411

Molecule Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Vaccines
• Cell Gene Therapy
• Others

Therapeutic Area Outlook (Revenue, USD Billion, 2021 - 2026)
• Hematology
• Oncology
• Infectious Disease
• Neurology
• Metabolic Disorders/Endocrinology
• Cardiovascular System Disorders
• Ophthalmology
• Immunological Disorders
• Dermatology
• Psychiatry
• Gastrointestinal Diseases
• Genitourinary & Women’s Health
• Others

Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Clinical Research Services
• Early-Phase Development Services
• Laboratory Services
• Consulting Services
• Data Management Services

End-User Outlook (Revenue, USD Billion, 2021 - 2026)
• Pharmaceutical and Biopharmaceutical
• Academic Institutes
• Medical Device Components

Regional Outlook (Revenue, USD Billion, 2021 – 2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Chile
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: [email protected]
Phone Number: +16026667238
Website: Global Market Estimates
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php